The PD-1 protein has two ligands, programmed cell death ligand-1 (PD-L1) and programmed cell death ligand-2, in which PD-L1 expresses on the surface of tumor cells and bind to PD-1-expressing T cells, causing T cell exhaustion and evasion of immune surveillance. This evidence concerns the gene CD274 and neoplasm.